美托洛尔对高血压性心脏病患者QT间期离散度及心律失常的效果分析  

Effect of Metoprolol on QT Interval Dispersion and Arrhythmia in Patients with Hypertensive Heart Disease

作　　者：毕莎莎[1] BI Sha-sha(Department of Cardiology,Dalian Central Hospital,Dalian 116033,China)

机构地区：[1]大连市中心医院心内科

出　　处：《中国医药指南》2019年第28期4-4,6,共2页Guide of China Medicine

摘　　要：目的测定酒石酸美托洛尔对高血压性心脏病合并心律失常患者的临床疗效。方法选取2017年1月至2017年12月前来就诊的高血压心脏病患者122例,把他们随机分为2组,即对照组和观察组,分别为60例和62例,对照组予以常规抗心律失常治疗,观察组在对照组的基础上加服美托洛尔,观察两组的QTd、室性心律失常发生率、左心室壁厚度。结果治疗后观察组QTd及心律失常发生率较对照组好转,差异具有统计学意义(P<0.05)。结论托洛尔可降低高血压心脏病患者的QT间期离散度及改善心室功能,临床效果优异,值得广泛推广应用。Objective To determine the clinical efficacy of metoprolol tartrate in patients with hypertensive heart disease complicated with arrhythmia.Methods 122 cases of hypertensive heart disease were selected from January 2017 to December 2017.They were randomly divided into 2 groups,namely,the control group and the observation group,60 cases and 62 cases respectively.The control group was treated with conventional antiarrhythmic treatment.The observation group applied metoprolol on the basis of the control group and observed the QTd and ventricular heart in the two groups.The incidence of arrhythmia and the thickness of left ventricular wall.Results After treatment,the incidence of QTd and arrhythmia in the observation group was better than that in the control group,and the difference was statistically significant(P<0.05).Conclusion It can reduce the dispersion of QT interval and improve ventricular function in patients with hypertensive heart disease.It is worthy of wide application.

关 键 词：高血压性心脏病 心率失常 临床观察 

分 类 号：R541.3[医药卫生—心血管疾病]